• 제목/요약/키워드: MMSE-K & GDS

검색결과 51건 처리시간 0.032초

인지재활 프로그램이 지역사회노인의 인지기능에 미치는 영향 (The Effect Of Cognitive Rehabilitative Programs on The Cognitive Function of Elderly People in The Community)

  • 이선명
    • 한국임상보건과학회지
    • /
    • 제5권3호
    • /
    • pp.936-942
    • /
    • 2017
  • Purpose. The purpose of this study was to determine the effect of cognitive based programs on cognitive functions in elderly people. Methods. The participants included a group of 9 elderly people in Changwon, from the period of May 2016 to July 2016. The test tools used were MMES-K. SADL. and GDS. The statistics used was the 20.0 version. Results. According to the results of this study, the MMSE, GDS mean scores improved after implentation of the program, but no significant improvement was shown with SADL. The MMSE of the correlation coefficient was 0.785, and the GDS of the correlation coefficient was 0.916. Both of these scores were significant in their correlation. Conclusion. In conclusion, cognitive based programs were effective among mildly cognitive-impaired elderly people, and that suitable programs must be developed on a case by case basis.

노인의 치매행동 관련 홀니스 프로그램 개발과 완충효과 검증 (The Development of Wholeness Program for Effects Dementia-Buffering Testing of the Demented Elderly)

  • 홍혜전
    • 한국체육학회지인문사회과학편
    • /
    • 제57권1호
    • /
    • pp.405-419
    • /
    • 2018
  • 이 연구는 치매행동 관련 홀니스 프로그램 적용 및 완충효과 검증 단계로 서울시에 위치한 M1과 M2 노인복지관에 개설되어 있는 주간보호시설 참여 노인 총 40명을 대상자로 선정하였다. 선정된 대상자들의 사전조사를 실시한 후 무작위로 M1노인복지관 노인 20명을 실험군으로, M2노인복지관 노인 20명을 통제군으로 배치하였다. 치매행동 관련 홀니스 프로그램 활동은 2016년 3월 14일부터 2016년 5월 30일까지 12주간, 주 2회, 60분간 수행하였다. 측정도구는 MMSE-K와 K-MBI, GDS-K를 사용하였다. 치매행동 관련 홀니스 프로그램에 참여하는 동안 치매행동 참여 전과 참여 후 총 2회를 측정하였으며 SPSS-PC(version 21.0) 통계프로그램을 이용하여 첫째, 실험군과 통제군의 동질성여부를 파악하기 위하여 독립표본 t-검증, 둘째, MMSE-K와 K-MBI, GDS-K에 대한 효과를 알아보기 위하여 사전검사와 사후검사 간 대응표본 t-검증, 셋째, 사전·사후 간 변화량을 확인하기 위하여 ANOVA를 실시하였다. 연구결과 노인의 치매행동 관련 홀니스 프로그램은 인지능력의 변화(MMSE-K), 신체능력의 변화(K-MBI), 우울수준의 변화(GDS-K)에 모두 효과가 있는 것으로 나타났다.

치매환자 여부와 혈중 납, 카드뮴, 수은 및 망간 농도와의 상관성 (Correlation between Dementia and Lead, Cadmium, Mercury, and Manganese Concentrations in the Blood)

  • 신미혜;이승길;김경희;최재욱
    • 한국환경보건학회지
    • /
    • 제46권3호
    • /
    • pp.267-275
    • /
    • 2020
  • Objectives: The causes of dementia have been reported in various ways, but there has been little research on the interrelationship between heavy metals and dementia, and the results also show little consistency. Therefore, it is imperative to compare the levels of heavy metal exposure between the dementia-suffering group and a control group to confirm the correlation between the level of heavy metal exposure and the likelihood of dementia. Methods: In order to assess the dementia level of the elderly, the Global Deterioration Scale (GDS) and Mini Mental State Examination (MMSE) were applied. To analyze the concentration of heavy metals in the blood, blood was collected from the veins of study subjects and measured using Inductively Coupled Plasma-mass spectrometry (ICP-MS). Results: There was a statistically significant correlation between lead and manganese concentrations in the blood and the MMSE and GDS. It was found that there was a statistically significant correlation between cadmium concentration in the blood and the GDS, but the MMSE was less relevant. It was found that the blood mercury concentration and the MMSE and GDS were less relevant. The lead concentration in the blood was 0.95±0.74 ㎍/dL in the dementia patient group and 0.33±0.22 ㎍/dL in the normal group, while cadmium was 0.69±0.37 ㎍/L in the dementia group and 0.18±0.10 ㎍/L in the normal group. Mercury was 0.81±0.31 ㎍/L in the dementia group and 1.16±0.80 ㎍/L in the normal group. Manganese was 6.83±2.01 ㎍/L in the dementia group and 4.78±1.59 ㎍/L in the normal group. All of these show statistically significant differences. Conclusions: As the concentration of lead, cadmium and manganese in the blood increases, the MMSE scores and GDS scores were found to worsen, and it was confirmed that there is a correlation between heavy metal exposure and cognitive degradation.

치매 환자의 매선 요법 치료에 관한 치험 3예 (The Case Report of 3 Dementia Patients Treated by Needle-Embedding Therapy)

  • 배달빛;박장호;유윤선;이고은;정현국;강형원;유영수
    • 동의신경정신과학회지
    • /
    • 제23권3호
    • /
    • pp.99-116
    • /
    • 2012
  • Objectives : The purpose of this study is to evaluate the effects of Needle-Embedding Therapy on dementia patients. Methods : We recruited 3 dementia patients who have been experiencing memory disorder and orientation disorder. The patients had been evaluated with Mini-Mental State Examination-K (MMSE-K), Global Deterioration Scale (GDS) and Clinical Dementia Rating (CDR). The patients were treated with herbal medication (Sunghyangjunggi-san) and acupuncture. After 15 days, the patients were added to Needle-Embedding Therapy. We measured MMSE-K, GDS and CDR for every 15 days. The effects of additional Needle-Embedding Therapy were compared with the effects of acupuncture and herbal medicine. Results : After Needle-Embedding Therapy was added, Patients' memory and orientation have been improved and the score of MMSE-K ascended. The grade of GDS and CDR were maintained or decreased. Conclusions : This study suggests that Needle-Embedding Therapy is significantly effective on Dementia patients.

일개 보건소 한의약 경도인지장애 관리프로그램의 효과분석 (The Effect of Mild Cognitive Impairment Management Program on Traditional Korean Medicine in a Public Health Center)

  • 김경한;이수인
    • 대한한의학회지
    • /
    • 제34권3호
    • /
    • pp.106-118
    • /
    • 2013
  • Objectives: The aim of this study was to evaluate the effect of a mild cognitive impairment (MCI) management program on traditional Korean medicine in a public health center. Methods: In order to examine the effect of the MCI management program, we investigated MCI patients who participated in the program. MCI patients were treated with Jodeung-san (JDS) or Dangguijagyag-san (DGJYS) for 6 weeks. Mini Mental State Examination-Dementia Screening (MMSE-DS), Geriatric Quality of Life-Dementia (GQOL-D), Geriatric Depression Scale in Korea (GDS-K), and biochemical examination of blood were conducted at intervals of 6 weeks. A satisfaction survey was collected after this program. Results: MMSE-DS mean score increased significantly, by 4.09 (p=0.000) in the JDS group and by 4.15 (p=0.000) in the DGJYS group. GQOL-D mean score also increased significantly, by 5.90 (p=0.000) in the JDS group and by 5.07 (p=0.000) in the DGJYS group. GDS-K mean score decreased significantly, by 10.63 (p=0.000) in the JDS group and by 9.69 (p=0.000) in the DGJYS group. MMSE-DS, GDS-K and GQOL-D scores were not significantly different between the JDS and DGJYS groups. All of the participants were satisfied with the program, and 90% of the participants expressed a high intention to participate in the program again. Conclusions: Both Jodeung-san and Dangguijagyag-san treatment showed improvement on cognitive function, depression and quality of life in this program. Additional studies with more subjects will be required to prove credibility and validity more clearly.

혈관성 치매 환자 치험 3례 (Three cases of Vascular Dementia Patients)

  • 장문희;최재송;배나영;안택원
    • 사상체질의학회지
    • /
    • 제23권3호
    • /
    • pp.402-411
    • /
    • 2011
  • 1. Objectives: This study is about three vascular dementia patients with disorientation, memory impairment and cognitive disorder. In this study, we evaluated the effects of Sasang constitutional treatment and suggested using the Mini Mental Status Examination - Korea (MMSE-K), Global Deterioration Scale (GDS). 2. Methods: These three patients were treated by Sasang constitutional herbal medications based on "Donguisusebowon". Acupuncture and west medications were limited as much as possible. We evaluated the symptoms through the Mini Mental Status Examination - Korea (MMSE-K), GDS (Global Deterioration Scale). 3. Results and Conclusions: Disorientation, memory impairment and cognitive disorder that were these three patients chief complaints were improved. This case study shows that Sasang constitutional herbal medications are an effective treatment for vascular dementia patients.

알츠하이머병과 경도인지장애에서 체질량지수와 인지기능과의 연관성 (Association of Body Mass Index and Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment)

  • 임은정;이강준;김현
    • 정신신체의학
    • /
    • 제24권2호
    • /
    • pp.184-190
    • /
    • 2016
  • 연구목적 본 연구는 알츠하이머병(Alzheimer's disease, AD), 경도인지장애(Mild Cognitive Impairment, MCI), 정상군에서 체질량지수(Body Mass Index, BMI)의 차이를 분석하여 낮은 BMI 수치와 인지기능 저하와의 연관을 확인하고자 하였다. 또한, 한국판 간이정신상태검사(Mini Mental State Examination-Korean version, MMSEK), 치매임상평가척도(Clinical Dementia Rating, CDR), 전반적 퇴화척도(Global Deterioration Scale, GDS)과 BMI 사이에 연관성이 있는지도 알아보고자 하였다. 방 법 총 257명의 연구대상자들이 이 연구에 포함되었고, AD 및 MCI 진단을 위해 병력 청취, 정신상태검사, 신경인지기능검사, 신체 검사가 시행되었다. 대상자의 성별 및 연령과 신체 질환도 함께 조사하였다. 전반적인 인지기능과 질병의 심각도 단계 평가는 MMSE-K, GDS, CDR으로 측정하였다. 결 과 MMSE-K 점수는 정상군>MCI>AD 순이었으며 통계적으로 유의한 차이를 나타내었다(p=0.000). CDR과 GDS점수는 정상군이 가장 높았고, AD군이 가장 낮았으며 역시 통계적으로 유의한 차이를 나타내었다 BMI와 MMSE 점수 사이에는 유의한 양의 상관관계가 있었다(r=0.238, p=0.000). BMI와 CDR과는 음의 상관관계를 나타내었으며(r=-0.174, p=0.008), BMI와 GDS 역시, 음의 상관관계를 보였다(r=-0.233, p=0.000). 결 론 BMI와 인지기능과의 연관성이 있으므로, 치매나 경도인지장애 환자를 대상으로 BMI를 측정하는 것은 임상적 표지자로서 의미가 있을 것으로 예상된다. 본 연구는 AD의 진단 및 예방, 그리고 치료적 접근에 도움을 줄 수 있을 것으로 기대하며, 향후 이에 대한 대규모의 장기 추적 연구가 필요할 것으로 생각된다.

Association of head circumference with cognitive decline and symptoms of depression in elderly: a 3-year prospective study

  • Kwon, Oh Dae;Choi, So-Young;Bae, Jisuk
    • Journal of Yeungnam Medical Science
    • /
    • 제35권2호
    • /
    • pp.205-212
    • /
    • 2018
  • Background: Brain volume is associated with dementia and depression in the elderly. An easy way to predict relative brain volume is to measure head circumference. In this study, we investigated the relationship between head circumference and cognition as well as depression in a non-demented elderly community. Methods: Baseline and follow-up surveys were conducted in 2007 and 2010. At baseline, community residents aged 65 years or over (n=382) within a rural area of South Korea were screened for dementia and symptoms of depression and were followed using the same screening battery after 3 years (n=279). Data from anthropometric measurements (head circumference, height, and body weight), demographics, and blood tests were gathered. Neuropsychological tests, including the Korean version of mini-mental state examination (K-MMSE), clinical dementia rating (CDR) including the CDR-sum of boxes, the Korean version of instrumental activities of daily living, and geriatric depression scale (GDS), were performed. None of the 279 subjects followed were demented. Results: Baseline performance on the K-MMSE and GDS was poorer for participants with smaller head circumferences. Follow-up performance on the MMSE was also poorer for participants with smaller head circumferences. Interestingly, participants with smaller head circumference showed worse GDS scores at baseline but on follow-up examination, participants with larger head circumference showed rapid worsening than those with smaller head circumference with marginal significance by ANOVA test. In regression coefficient analysis, GDS decline showed significant difference. Conclusion: Head circumference was not associated with cognitive change but was associated with symptoms of depression in non-demented community residents.

경도인지장애, 알쯔하이머형 치매 환자에서 우울증상 유무에 따른 혈중 호모시스테인의 차이 (The Differences of Serum Homocysteine Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type with or without Depressive Symptoms)

  • 황보람;김현;이강준
    • 정신신체의학
    • /
    • 제22권1호
    • /
    • pp.40-45
    • /
    • 2014
  • 연구목적 경도인지장애와 치매는 인지기능의 퇴행과 우울 등과 같은 신경정신증상을 나타낸다. 이들의 진단에 도움을 줄 수 있는 다양한 진단 도구 중 혈중 호모시스테인 농도를 측정하는 방법이 있으며, 연구에 따르면 혈중 호모시스테인 농도의 증가는 알쯔하이머병, 우울증 그리고 다른 신경정신질환의 발생위험을 증가시킨다. 본 연구는 혈중 호모시스테인이 인지기능장애와 연관된다는 사실을 기초로 경도인지장애와 알쯔하이머형 치매에서 우울증상 유무에 따른 혈중 호모시스테인 농도를 분석해보았다. 방법 경도인지장애, 알쯔하이머형 치매로 진단된 환자 86명이 참여하였고 혈액검사를 통해 혈중 호모시스테인 농도를 측정하였다. 환자들의 전반적인 인지기능 및 심각도의 단계 평가는 한국판 간이정신상태검사(MMSE-KC)와 전반적 퇴화척도(Global Deterioration Scale, GDS), 치매임상평가척도(Clinical dementia rating, CDR)를 이용하여 측정하였고, 우울증상 유무에 대한 평가는 한국판 노인우울척도(Korean version of Geriatric Depression Scale, K-GDS)를 통해 측정하였다. 결과 혈중 호모시스테인 농도는 경도인지장애군 중 우울증상이 있는 군에서 우울증상이 없는 군보다 통계적으로 유의한 높은 수치를 보였다. 치매환자군에서는 우울증상이 있는 군과 우울증상이 없는 군사이에 통계적으로 유의한 차이는 없었다. 상관분석에서 혈중 호모시스테인 농도와 MMSE-KC는 유의한 음의 상관 관계를 보였고, CDR, GDS는 유의한 양의 상관 관계를 보였다. 결론 이러한 결과는 혈중 호모시스테인 농도의 증가가 인지기능저하와 우울증의 위험인자라는 사실을 나타낸다. 특히 본 연구에서는 경도인지장애 환자군에서 혈중 호모시스테인 농도와 우울증상 간의 의미있는 연관성을 제시하였다. 본 연구 중의 몇 가지 제한점을 보완한 좀 더 대규모의 연구가 필요하다.

  • PDF

Verification of the Reliability and Validity of a Virtual Reality Cognitive Evaluation System Based on Motion Recognition Analysis Evaluation

  • Jeonghan Kwon;Subeen Kim;Jongduk Choi
    • 한국전문물리치료학회지
    • /
    • 제30권4호
    • /
    • pp.306-313
    • /
    • 2023
  • Background: As social problems due to the acceleration of the aging era and the increase in the elderly population are becoming serious, virtual reality (VR)-based healthcare is emerging as an approach for preventing and managing health issues. Objects: This study used validity and reliability analyses to examine the clinical efficacy that is, the clinical value and usability of a novel VR cognitive evaluation system index that we developed. Methods: We developed a VR cognitive evaluation system based on motion recognition analysis evaluation for individuals aged 65 to 85. After conducting the Korean version of the Mini-Mental State Exam (K-MMSE) cognitive evaluation, the evaluation score was verified through correlation analysis in the VR cognitive evaluation system. To verify the construct validity of the two groups, the Global Deterioration Scale (GDS) grades were categorized into a normal cognitive group (GDS grade 1) and a cognitive impairment group (GDS grades 2 and 3). The data were measured twice to determine the reliability between the two measurements and assess the stability and clinical value of the evaluation system. Results: Our evaluation system had a high correlation of 0.85 with the widely used K-MMSE cognitive evaluation. The system had strong criterion-related validity at the 95% confidence interval. Compared to the average score of GDS grade 1 in the VR cognitive evaluation system, the average score of GDS grades 2 and 3 in the VR cognitive evaluation system was statistically significantly lower while also having strong construct validity at the 95% confidence interval. To measure the reliability of the VR cognitive evaluation system, tests-retests were conducted using the intraclass correlation coefficient (3,1), which equaled 0.923 and was statistically significant. Conclusion: The VR cognitive evaluation system we developed is a valid and reliable clinical tool to distinguish between normal cognitive status and mild cognitive impairment.